I guess what I'm trying to understand is if we will get to the point that a patient can be treated with the Cytosorbents filter in a medical doctor's office outside of a hospital. Oncology doctors can treat patients in a regular doctors office with chemo drips for example. This brings up an entire new potential and makes predicting future revenues that more difficult. Is that why the focus I'm hearing on message boards is on monthly filter production numbers for revenues. This has the potential to be ma$$ive !
The administration has asked Congress for an additional $2.5 billion to speed development of a vaccine, support preparedness and response activities, and to gather needed equipment and supplies.
He said a vaccine that people can use is a year to a year-and-a-half away “at best.”
*************** If it goes epidemic, we don't have "a year-and-a-half away “at best.”"
Can CTSO pursue obtaining funds once the money is authorized? How? Big Pharma gatekeepers?
"Has any organization produced a best count estimate of hospital/medical treatment centers in every country to help with accounting guidance etc.?"
maybe these people know, at least the USA
Association of State and Territorial Health Officials https://www.astho.org/ ******************************************************** National Association of County and City Health Officials https://www.naccho.org/ ********************************************************* Association of Public Health Laboratories. https://www.aphl.org/Pages/default.aspx ************************************************* Council of State and Territorial Epidemiologists https://www.cste.org/
Market Data 
Markets 
AI
